Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Change in Account Payables came in at $6.8 million in Q1 2026, up 152.17% YoY from $2.7 million in Q1 2025, and up 172.64% on a QoQ basis from -$9.4 million in Q4 2025.
Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Change in Account Payables data on file, last reported at $6.8 million in Q1 2026.
- Quarterly Change in Account Payables rose 152.17% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314000.0 (up 103.96% YoY) and the FY2025 annual result came in at -$3.8 million, down 189.11% from the prior year.
- Change in Account Payables improved to $6.8 million in Q1 2026, from -$9.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $9.3 million in Q1 2024 to a low of -$9.4 million in Q4 2025.
- A 5-year average of $557705.9 and a median of $576000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 1098.33% — and 2025, when it slumped 769.44%.
- Tracing TMCI's Change in Account Payables over 5 years: stood at $787000.0 in 2022, then jumped by 300.89% to $3.2 million in 2023, then slumped by 357.59% to -$8.1 million in 2024, then slipped by 15.38% to -$9.4 million in 2025, then surged by 172.64% to $6.8 million in 2026.
- The last three Change in Account Payables figures came in at $6.8 million (Q1 2026), -$9.4 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Treace Medical Concepts | 283.62 Mn | 238.00 Mn | 35.61 Mn | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Mn |
| Jun 30, 2026 | 2.52 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Sep 30, 2024 | 576,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Mar 31, 2024 | 9.31 Mn |